释放潜力:通过预测算法驱动的数字治疗来为2型糖尿病提供个性化的生活方式治疗
Swantje Kannenberg1, Jenny Voggel2, Nils Thieme2
1Diabetes Plus, Diabetology Medical Practice, Lübeck, Germany.
Journal of diabetes science and technology
|July 31, 2024
概括
与人工智能和持续葡萄糖监测 (CGM) 结合的数字治疗 (DTx) 改善了2型糖尿病 (T2D) 患者的血糖控制和体重减轻. 这种非药物解决方案为T2D管理提供了显著的进步.
科学领域:
- 数字健康干预措施 数字健康干预措施
- 医学中的人工智能.
- 糖尿病管理 糖尿病管理
背景情况:
- 通过个性化的生活方式干预,可以改善2型糖尿病 (T2D) 的管理.
- 数字疗法 (DTx) 为慢性疾病管理提供了一种新的方法.
研究的目的:
- 评估一个集成持续血糖监测 (CGM) 和人工智能的数字疗法 (DTx),用于T2D的个性化生活方式干预.
- 评估DTx对血糖控制,体重和生活质量的影响.
主要方法:
- 一项涉及118名非胰岛素治疗T2D (HbA1c ≥6.5%) 的参与者接受标准护理的研究.
- 参与者使用了DTx三个月,并进行了临床终点的前后比较.
- 还评估了第二次使用DTx的长期数据.
主要成果:
- 在整个队列中,HbA1c改善0.67%,在三个月后 (P<.001) 控制不良的患者中,HbA1c降低-1.08% (HbA1c≥7.0%).
- 治疗目标范围 (<7.0%) 从38%增加到60%;33%接近缓解 (<6.5%).
- 第二次使用DTx的用户在六个月后显示HbA1c降低了-0.76%和体重减轻了-6.84公斤 (P <.001).
结论:
- DTx显示了对T2D患者的血糖控制和体重减轻的临床相关影响.
- 数字化解决方案在单次或重复使用的情况下,对控制良好和控制不良的糖尿病都有效.
- 这种非药物DTx,集成CGM生物反和AI,代表了T2D管理的重大进步.
相关概念视频
Diabetes: Management and Pharmacotherapy
250
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
250
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Carbohydrate Metabolism
10.9K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.9K
Insulin: Dosing Regimen and Adverse Effects
163
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
163
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


